Total Liabilities Summary of Medistim ASA

Medistim ASA's latest annual total liabilities in 2023 was 107.77 Million NOK , down -6.25% from previous year.
Medistim ASA's latest quarterly total liabilities in 2024 Q3 was 85.93 Million NOK , down -8.19% from previous quarter.
Medistim ASA reported annual total liabilities of 114.96 Million NOK in 2022, up 18.29% from previous year.
Medistim ASA reported annual total liabilities of 97.19 Million NOK in 2021, up 9.24% from previous year.
Medistim ASA reported quarterly total liabilities of 85.93 Million NOK for 2024 Q3, down -8.19% from previous quarter.
Medistim ASA reported quarterly total liabilities of 93.59 Million NOK for 2024 Q2, down -4.9% from previous quarter.

Annual Total Liabilities Chart of Medistim ASA (2023 - 2004)

Historical Annual Total Liabilities of Medistim ASA (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	107.77 Million NOK	-6.25%
2022	114.96 Million NOK	18.29%
2021	97.19 Million NOK	9.24%
2020	88.97 Million NOK	-10.35%
2019	99.24 Million NOK	57.84%
2018	62.88 Million NOK	-7.64%
2017	68.08 Million NOK	35.23%
2016	50.34 Million NOK	-19.15%
2015	62.27 Million NOK	-3.29%
2014	64.39 Million NOK	37.72%
2013	46.75 Million NOK	27.41%
2012	36.69 Million NOK	-14.14%
2011	42.74 Million NOK	12.15%
2010	38.11 Million NOK	-3.11%
2009	39.33 Million NOK	-21.21%
2008	49.92 Million NOK	42.82%
2007	34.95 Million NOK	-22.47%
2006	45.09 Million NOK	156.44%
2005	17.58 Million NOK	40.95%
2004	12.47 Million NOK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	98.41 Million NOK	-8.68%
2024 Q3	85.93 Million NOK	-8.19%
2024 Q2	93.59 Million NOK	-4.9%
2023 Q3	96.63 Million NOK	9.81%
2023 Q1	100.35 Million NOK	-12.71%
2023 Q2	87.99 Million NOK	-12.31%
2023 FY	107.77 Million NOK	-6.25%
2023 Q4	107.77 Million NOK	11.54%
2022 Q2	88.56 Million NOK	-11.23%
2022 FY	114.96 Million NOK	18.29%
2022 Q3	86.74 Million NOK	-2.06%
2022 Q4	114.96 Million NOK	32.54%
2022 Q1	99.76 Million NOK	2.65%
2021 Q3	80.92 Million NOK	13.83%
2021 Q2	71.08 Million NOK	-15.16%
2021 Q4	97.19 Million NOK	20.1%
2021 Q1	83.78 Million NOK	-5.83%
2021 FY	97.19 Million NOK	9.24%
2020 Q1	91.95 Million NOK	-7.35%
2020 Q2	82.17 Million NOK	-10.63%
2020 Q3	95.79 Million NOK	16.58%
2020 Q4	88.97 Million NOK	-7.13%
2020 FY	88.97 Million NOK	-10.35%
2019 Q2	56.26 Million NOK	-9.83%
2019 Q3	59.11 Million NOK	5.07%
2019 Q4	99.24 Million NOK	67.88%
2019 FY	99.24 Million NOK	57.84%
2019 Q1	62.39 Million NOK	-0.77%
2018 Q1	61.71 Million NOK	-9.35%
2018 Q4	62.88 Million NOK	17.47%
2018 Q2	48.43 Million NOK	-21.52%
2018 Q3	53.52 Million NOK	10.51%
2018 FY	62.88 Million NOK	-7.64%
2017 FY	68.08 Million NOK	35.23%
2017 Q4	68.08 Million NOK	17.23%
2017 Q3	58.07 Million NOK	2.52%
2017 Q2	56.64 Million NOK	13.74%
2017 Q1	49.8 Million NOK	-1.08%
2016 Q3	46.85 Million NOK	-0.67%
2016 FY	50.34 Million NOK	-19.15%
2016 Q2	47.17 Million NOK	-13.1%
2016 Q4	50.34 Million NOK	7.45%
2016 Q1	54.28 Million NOK	-12.83%
2015 FY	62.27 Million NOK	-3.29%
2015 Q1	59.57 Million NOK	-7.47%
2015 Q2	106.35 Million NOK	78.52%
2015 Q3	58.31 Million NOK	-45.17%
2015 Q4	62.27 Million NOK	6.78%
2014 Q3	54.73 Million NOK	1.53%
2014 Q1	42.23 Million NOK	-9.67%
2014 FY	64.39 Million NOK	37.72%
2014 Q4	64.39 Million NOK	17.63%
2014 Q2	53.91 Million NOK	27.65%
2013 Q4	46.75 Million NOK	10.07%
2013 Q2	43.98 Million NOK	34.17%
2013 Q1	32.78 Million NOK	-10.66%
2013 FY	46.75 Million NOK	27.41%
2013 Q3	42.47 Million NOK	-3.43%
2012 Q2	45.98 Million NOK	13.7%
2012 Q1	40.44 Million NOK	-5.36%
2012 Q3	35 Million NOK	-23.88%
2012 FY	36.69 Million NOK	-14.14%
2012 Q4	36.69 Million NOK	4.83%
2011 Q2	40.18 Million NOK	12.72%
2011 Q4	42.74 Million NOK	19.36%
2011 FY	42.74 Million NOK	12.15%
2011 Q1	35.64 Million NOK	-6.46%
2011 Q3	35.8 Million NOK	-10.88%
2010 FY	38.11 Million NOK	-3.11%
2010 Q3	33.13 Million NOK	-5.54%
2010 Q2	35.08 Million NOK	-3.36%
2010 Q1	36.3 Million NOK	-7.71%
2010 Q4	38.11 Million NOK	15.0%
2009 FY	39.33 Million NOK	-21.21%
2009 Q4	39.33 Million NOK	0.0%
2008 FY	49.92 Million NOK	42.82%
2007 FY	34.95 Million NOK	-22.47%
2006 FY	45.09 Million NOK	156.44%
2005 FY	17.58 Million NOK	40.95%
2004 FY	12.47 Million NOK	0.0%

Peer Total Liabilities Comparison of Medistim ASA

Name	Total Liabilities	Total Liabilities Difference
Gentian Diagnostics ASA	33.65 Million NOK	-220.25%
Lifecare AS	19.93 Million NOK	-440.633%

Global Stocks Search

Medistim ASA (MEDI.OL)

Total Liabilities Summary of Medistim ASA

Annual Total Liabilities Chart of Medistim ASA (2023 - 2004)

Historical Annual Total Liabilities of Medistim ASA (2023 - 2004)

Peer Total Liabilities Comparison of Medistim ASA